In vivo diagnosis of cardiac angiosarcoma by endomyocardial biopsy
Insights
Diagnosing primary heart tumors like angiosarcoma is now possible using minimally invasive transvenous endomyocardial biopsy, avoiding open-chest surgery. This technique enables precise in vivo histological diagnosis of cardiac malignancies.
Area of Science:
- Cardiology
- Oncology
- Pathology
Background:
- Primary heart tumors are rare and typically diagnosed via imaging and post-surgical examination.
- Current diagnostic methods often require invasive surgical procedures for confirmation.
Purpose of the Study:
- To report a case of primary cardiac angiosarcoma diagnosed using transvenous endomyocardial biopsy.
- To demonstrate the feasibility of in vivo histological diagnosis for malignant cardiac tumors without thoracotomy.
Main Methods:
- Transvenous endomyocardial biopsy was performed on a 36-year-old male patient with a right atrioventricular mass.
- Cardiac imaging (echocardiography, MRI) was used for initial assessment.
- Histopathological examination of the biopsy confirmed angiosarcoma.
Main Results:
- Angiosarcoma was accurately diagnosed in vivo via endomyocardial biopsy.
- Pulmonary metastases were identified, precluding surgical intervention.
- The patient survived for 12 months post-diagnosis.
Conclusions:
- Transvenous endomyocardial biopsy is a viable method for precise in vivo histological diagnosis of malignant primary cardiac tumors.
- This minimally invasive approach can obviate the need for thoracotomy in diagnosing cardiac malignancies.
- Early and accurate diagnosis can inform treatment strategies and prognosis for patients with primary cardiac tumors.
Abstract:
The present-day diagnosis of primary heart tumors is achieved by cardiac imaging and confirmed by morphological examination after surgical resection. We describe the case of a 36-year-old man with a right atrioventricular mass in whom angiosarcoma was diagnosed by transvenous endomyocardial biopsy. Surgery was not attempted because of pulmonary metastases, and the patient died 12 months later. This experience indicates that precise in vivo histological diagnosis of malignant primary cardiac tumor is possible without thoracotomy.
